Literature DB >> 23226823

Diagnosis of microvillous inclusion disease: a case report and literature review with significance for oman.

Siham Al-Sinani1, Sharef Waadallah Sharef, Ritu Lakhtakia, Mohamed Abdellatif.   

Abstract

Microvillous Inclusion Disease (MVID) is one of the congenital diarrheal disorders (CDD) caused by genetic defects in enterocyte differentiation and polarization. Its prevalence is higher in countries with a high degree of consanguinity. It causes severe, intractable secretory diarrhea leading to permanent and definitive intestinal failure with resultant dependency on parenteral nutrition (PN). Small bowel transplantation is the only curative treatment. The gold standard for diagnosis are the typical morphological abnormalities in small bowel biopsies on light and electron microscopy (EM). In recent times, histochemistry and immunohistochemistry have shown sufficient diagnostic accuracy replacing EM if the facility is unavailable or EM findings are inconclusive. We describe a neonate with CDD who was diagnosed to have MVID on the duodenal biopsy by morphohistochemical and immunophenotypic methods used for the first time in Oman. By utilizing such easy and accessible diagnostic methods, a rare genetic disorder could be diagnosed with certainty and the family could be counseled accordingly. With a high degree of consanguinity in the region, the prevalence of MVID in Oman needs to be identified once these patients are diagnosed by utilizing appropriate investigations. Care of such patients necessitates improving current parenteral nutrition services and addressing the future need for small bowel transplantation (SBTx), in Oman.

Entities:  

Keywords:  Congenital diarrheal disorder; Intestinal transplantation; Microvillous Inclusion Disease; Small intestine biopsy

Year:  2012        PMID: 23226823      PMCID: PMC3515048          DOI: 10.5001/omj.2012.119

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  19 in total

1.  Microvillous inclusion disease: an evolving condition.

Authors:  N M Croft; A G Howatson; S C Ling; L Nairn; T J Evans; L T Weaver
Journal:  J Pediatr Gastroenterol Nutr       Date:  2000-08       Impact factor: 2.839

2.  Microvillous inclusion disease. The importance of electron microscopy for diagnosis.

Authors:  S W Bell; J A Kerner; R K Sibley
Journal:  Am J Surg Pathol       Date:  1991-12       Impact factor: 6.394

3.  Loss-of-function of MYO5B is the main cause of microvillus inclusion disease: 15 novel mutations and a CaCo-2 RNAi cell model.

Authors:  Frank M Ruemmele; Thomas Müller; Natalia Schiefermeier; Hannes L Ebner; Silvia Lechner; Kristian Pfaller; Cornelia E Thöni; Olivier Goulet; Florence Lacaille; Jacques Schmitz; Virginie Colomb; Frédérique Sauvat; Yann Revillon; Danielle Canioni; Nicole Brousse; Genevieve de Saint-Basile; Juliette Lefebvre; Peter Heinz-Erian; Axel Enninger; Gerd Utermann; Michael W Hess; Andreas R Janecke; Lukas A Huber
Journal:  Hum Mutat       Date:  2010-05       Impact factor: 4.878

4.  [CD10 expression in a case of microvillous inclusion disease].

Authors:  Nelly Youssef; Frank M Ruemmele; Olivier Goulet; Natacha Patey
Journal:  Ann Pathol       Date:  2004-12       Impact factor: 0.407

5.  Long-term outcome of children receiving home parenteral nutrition: a 20-year single-center experience in 302 patients.

Authors:  Virginie Colomb; Myriam Dabbas-Tyan; Pierre Taupin; Cécile Talbotec; Y Révillon; D Jan; Sophie De Potter; Anne-Marie Gorski-Colin; Michèle Lamor; Karen Herreman; Odile Corriol; Paul Landais; Claude Ricour; Olivier Goulet
Journal:  J Pediatr Gastroenterol Nutr       Date:  2007-03       Impact factor: 2.839

6.  New perspectives for children with microvillous inclusion disease: early small bowel transplantation.

Authors:  Frank M Ruemmele; Dominique Jan; Florence Lacaille; Jean-Pierre Cézard; Danielle Canioni; Alan D Phillips; Michel Peuchmaur; Yves Aigrain; Nicole Brousse; Jacques Schmitz; Yann Revillon; Oliver Goulet
Journal:  Transplantation       Date:  2004-04-15       Impact factor: 4.939

7.  Long-term outcome, growth and digestive function in children 2 to 18 years after intestinal transplantation.

Authors:  F Lacaille; N Vass; F Sauvat; D Canioni; V Colomb; C Talbotec; N Patey-Mariaud De Serre; J Salomon; J-P Hugot; J-P Cézard; Y Révillon; F M Ruemmele; O Goulet
Journal:  Gut       Date:  2007-12-13       Impact factor: 23.059

8.  Serious renal impairment is associated with long-term parenteral nutrition.

Authors:  A L Buchman; A Moukarzel; M E Ament; J Gornbein; B Goodson; C Carlson; R A Hawkins
Journal:  JPEN J Parenter Enteral Nutr       Date:  1993 Sep-Oct       Impact factor: 4.016

9.  MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarity.

Authors:  Thomas Müller; Michael W Hess; Natalia Schiefermeier; Kristian Pfaller; Hannes L Ebner; Peter Heinz-Erian; Hannes Ponstingl; Joachim Partsch; Barbara Röllinghoff; Henrik Köhler; Thomas Berger; Henning Lenhartz; Barbara Schlenck; Roderick J Houwen; Christopher J Taylor; Heinz Zoller; Silvia Lechner; Olivier Goulet; Gerd Utermann; Frank M Ruemmele; Lukas A Huber; Andreas R Janecke
Journal:  Nat Genet       Date:  2008-08-24       Impact factor: 38.330

Review 10.  Microvillous inclusion disease (microvillous atrophy).

Authors:  Frank M Ruemmele; Jacques Schmitz; Olivier Goulet
Journal:  Orphanet J Rare Dis       Date:  2006-06-26       Impact factor: 4.123

View more
  3 in total

1.  Microvillous Inclusion Disease as a Cause of Protracted Diarrhea.

Authors:  Ravi Hari Phulware; Gaurav P S Gahlot; Rohan Malik; Siddhartha Datta Gupta; Prasenjit Das
Journal:  Indian J Pediatr       Date:  2019-05-02       Impact factor: 1.967

Review 2.  Porcine Intestinal Organoids: Overview of the State of the Art.

Authors:  Panpan Ma; Puxian Fang; Tianze Ren; Liurong Fang; Shaobo Xiao
Journal:  Viruses       Date:  2022-05-21       Impact factor: 5.818

3.  Editing Myosin VB Gene to Create Porcine Model of Microvillus Inclusion Disease, With Microvillus-Lined Inclusions and Alterations in Sodium Transporters.

Authors:  Amy C Engevik; Alexander W Coutts; Izumi Kaji; Paula Rodriguez; Felipe Ongaratto; Milena Saqui-Salces; Ramya Lekha Medida; Anne R Meyer; Elena Kolobova; Melinda A Engevik; Janice A Williams; Mitchell D Shub; Daniel F Carlson; Tamene Melkamu; James R Goldenring
Journal:  Gastroenterology       Date:  2020-02-26       Impact factor: 22.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.